Unemployment Is Bullish Now, Apparently

 

CLOSING BELL Good evening, and happy Friday. The market closed higher after terrible jobs numbers made the likelihood of a Fed rate raise look way worse. Yippie?  The Bureau of Labor Statistics said the number of jobs added to the U.S. economy in July was a negative 23k, lower than the hoped for +85,000. Seven of the past 18 months saw a subtraction in total jobs in the economy. The unemployment rate fell slightly from 4.2% to 4.1%, but only because the total number of job seekers declined.  Previous months lost another 103,000 jobs after revisions. Wall Street’s bad-news-is-good-news reflex returned, which is great until you remember why the news was bad. One user on Stocktwits said it felt like the stock market was celebrating like the movie The Big Short, when characters cheered that their bet against the market worked out, and Brad Pitt had to remind them they won because millions of people were losing their jobs.  Stocks traders chased company-level fireworks anyway: $DOCS clinical AI, $SPCX post-lockup relief, and $CELH’s activist challenge. The Dow crossed 54,000, but next week’s inflation data decides whether Friday bought investors a genuine policy pivot or merely a weekend sugar high.  Today's Briefing: Powered by Stocks Community API. After the Bell: Rockstar’s founder grabbed a 4.7% Celsius stake and demanded the CEO job  Stocks: Doximity’s AI pitch ignited a rally while SpaceX escaped its first major lockup  What's Trending Now on Stocks

AFTER THE BELL Rockstar Wants The Wheel Celsius Holdings, the energy-drink maker behind CELSIUS, Alani Nu, and Rockstar, surged Friday after Rockstar founder Russ Savage disclosed a 4.7% stake and demanded a leadership purge, offering to take the CEO job himself. The revolt arrived one session after an earnings miss sent shares down 18%.  The RIP: $CELH jumped 16.8% to $27.77 on 32.5M shares, 1.9x recent volume. Savage controls more than 12M shares worth roughly $300M, while Q2 adjusted EPS was $0.36 versus $0.42 expected and revenue was $817.9M versus $883M expected. The stock was lower after the report, but gained on the takeover push.  “The CEO has lost credibility with the investment community,” Savage told CNBC. Long-term holders now have two competing resets: John Fieldly’s plan to restore core CELSIUS growth and Savage’s plan to replace the people running it. Management expects third-quarter core-brand performance to resemble Q2 before growth returns exiting 2026, while Savage wants the CEO, COO, brand manager, and marketing manager gone. Watch whether the 11.7% core-brand revenue decline narrows, because boardroom fireworks will not win back shelf space.  The Community Read: The $CELH room is 95% bullish, see who backs Savage’s takeover ->

STOCKS Doctors Prescribed An AI Rally 🩺

Doximity, the digital platform for U.S. medical professionals, surged Friday after Thursday night’s earnings call turned a mixed quarter into an AI story. CEO Jeff Tangney said its clinical assistant beat U.S. rivals on a medical safety benchmark, while management raised its full-year revenue forecast.

The RIP:  $DOCS ( ▲ 32.62% ) jumped 32.6% to $27.40 on 65M shares, 9.3x recent volume. Adjusted EPS was $0.29 versus $0.30 expected, revenue rose 7% to $156.6M versus $151.8M expected, and fiscal 2027 revenue guidance increased to $671M–$681M from $664M–$676M.

“We're proving you can still post best-in-class software margins while investing heavily in clinical AI,” Tangney told analysts, according to Barron’s.

Growth investors got the AI acceleration they wanted, but the stock traveled from $40 to $27.16 intraday as enthusiasm met gravity. Doximity plans to spend more on clinical AI this fiscal year while guiding next-quarter revenue to $170M–$171M. Watch whether AI Search query growth above 25% sequentially can reverse the 7-point adjusted EBITDA margin compression, because doctors may love the product before shareholders love the bill.

The Community Read: The $DOCS room is 98% bullish, find the AI margin fight ->

SpaceX Clears The Launchpad

SpaceX, Elon Musk’s rocket, satellite internet, and AI company, ripped Friday after a stronger-than-expected quarter and Thursday’s release of 911.5M insider shares failed to trigger the feared selling wave. The rally snapped a four-week, 33% slide and pushed the newly public stock back toward its $135 IPO price.

The RIP: $SPCX jumped 15.8% to $133.11 on 237.6M shares, 1.6x recent volume. Q2 revenue was $7.8B versus $6.8B expected, adjusted EBITDA was $3.5B versus $2.1B expected, and analysts lifted 2027 revenue estimates to $102B from $72B.

Retail holders, who poured at least $3.6B into shares at an estimated $150 average, finally got relief after carrying roughly $4.5B in losses. The next unlock arrives later this month, while SpaceX could complete its $60B Cursor acquisition by the end of next week. The Community Read: The $SPCX room is 67% bullish, see who is buying the unlock ->

Trending Now $SOUN +13% | SoundHound: The beat gave bulls a bigger number to defend

58.4K WATCHERS · 92% BULLISH · EXTREMELY HIGH ACTIVITY

SoundHound AI delivered $61.9M in quarterly revenue, up 45%, and raised its full-year outlook to $230M–$260M as OASYS helped secure new enterprise deals. The 92% bullish room is betting those wins can turn rapid growth into actual profits before the valuation argument returns.

$OKLO +14% | Oklo: Criticality settled one question and opened another

39.1K WATCHERS · 74% BULLISH · LOW ACTIVITY

Oklo's Groves isotope test reactor achieved a controlled nuclear chain reaction less than a year after groundbreaking, while the company reported its first $1.2M revenue quarter. The milestone reduced execution risk, but traders remain split on how quickly a working test reactor can become a scalable commercial business.

$GLD +2% | Gold: The jobs shock put $400 back in play

95.7K WATCHERS · 68% BULLISH · HIGH ACTIVITY

SPDR Gold Shares climbed after U.S. employers unexpectedly cut 23,000 jobs in July and revisions erased another 103,000 from May and June, cooling rate expectations. The bullish room is now watching whether the move above $400 survives next week's inflation test or becomes another false breakout.